Madelynn N Whittaker
5PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 29, 2025
Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAs.Madelynn N Whittaker, Lauren C Testa, Aidan Quigley
|Oct 16, 2024
High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease.Vera Bzhilyanskaya, Linyuan Ma, Siyuan Liu
|Aug 17, 2023
Epigenome Editing Durability Varies Widely Across Cardiovascular Disease Target Genes.Madelynn N Whittaker, Lauren C Testa, Aidan Quigley
|Aug 15, 2023
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo.Yong Tao, Veronica Lamas, Wan Du
|Mar 29, 2020
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.Russell T Walton, Kathleen A Christie, Madelynn N Whittaker
Pageof 1
Frequent Collaborators
3 joint publications
Benjamin P Kleinstiver
2 joint publications
Kiran Musunuru
2 joint publications
Xiao Wang
1 joint publications
Russell T Walton
1 joint publications
Kathleen A Christie
1 joint publications
Arun Prabhu Rameshbabu
1 joint publications
Yilai Shu
1 joint publications
Xue Gao
1 joint publications
Wei-Jia Kong
1 joint publications
Zheng-Yi Chen
